Special Warning : אזהרת שימוש

4.4 Special warnings and precautions for use
Use during menses is not recommended.
Known or previously unrecognised candidiasis may present more prominent symptoms during therapy with Zidoval 7.5 mg/g vaginal gel and may require treatment with acandicidal agent.
If irritation does occur the patient should be advised to use metronidazole less frequently or to stop temporarily and to seek medical advice if necessary.
Metronidazole is a nitroimidazole and should be used with care in patients with evidence of a history of blood dyscrasias.
As with all vaginal infections, sexual intercourse during the infection and during treatment with Zidoval 7.5 mg/g vaginal gel is not recommended.
Unnecessary and prolonged use of this medication should be avoided. Evidence suggests that metronidazole is carcinogenic in certain animal species. There is no evidence to date of a carcinogenic effect in human (see section 5.3 preclinical safety data).

Zidoval 7.5 mg/g vaginal gel contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed).
Zidoval 7.5 mg/g vaginal gel also contains propylene glycol which may cause skin irritation.

Effects on Driving

4.7 Effects on ability to drive and use machines
Zidoval 7.5 mg/g vaginal gel has no influence on the ability to drive and use machines.